Analysis of main varieties of Chinese traditional medicine import and export to the Middle East in 2011

At present, the main botanical drugs imported from the Middle East include frankincense, myrrh, blood scorpion, essential oil (including extract and pure oil) of non citrus fruits and cumingzi Due to the large increase of domestic demand for liquorice juice and extract, the products originally dominated by Turkmenistan and the United States have been unable to meet the market demand In 2011, some foreign-funded enterprises imported a large number of liquorice extract products from the United Arab Emirates, which led to a significant increase in China's import of botanical drugs from the Middle East in 2011 The largest export volume of Chinese herbal medicine to the Middle East is extract, accounting for 46% of the total export volume of Chinese herbal medicine to the Middle East; the fastest growing export volume is health products, while the export volume of Chinese herbal pieces has declined to a certain extent compared with 2011 At present, the main export commodities of Chinese medicine to the Middle East include cool oil, oil of crow grass, plant juice and extract, beeswax, turmeric, royal jelly preparation and bee pollen, etc Among them, the products with rapid year-on-year growth in export volume are mainly natural or synthetic glycosides and their salts, and the oil of Kadsura; the products with large year-on-year decline in export volume are mainly "natural or synthetic glycosides and their salts" and Chinese patent medicines (with fixed dose or retail packaging); the varieties with large year-on-year increase in average export price are mainly turmeric and bee pollen, and the average export price is lower than that of the previous year The main varieties with larger slip are natural or synthetic glycosides and their salts, plant juices and extracts.